EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 3.0

A minor metabolite from Curcuma longa effective against metabolic syndrome: results from a randomized, double-blind, placebo-controlled clinical study

Muhammed Majeed, Kalyanam Nagabhushanam, T V Devarajan, Santhosh Saklecha, S Venkata Krishna Reddy, Lakshmi Mundkur

Food & Function · 2023

DOI: 10.1039/d2fo03627d ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Food & Function, 2023. Verfasst von Muhammed Majeed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sami-Sabinsa Group Limited, 19/1&19/2, I Main, II Phase, Peenya Industrial Area, Bengaluru, Karnataka 560058, India. lakshmi@sami-sabinsagroup.com. Hauptthemen laut MEDLINE: Metabolic Syndrome, Insulin Resistance, Hypertension. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Randomized clinical trials show higher efficacy of Calebin A in managing metabolic syndrome in obese individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeInsulin ResistanceHypertensionAdultHumansObesity, AbdominalCurcumaObesityCholesterolInflammationDouble-Blind MethodBlood Glucose

Substanzen

CholesterolBlood Glucose

Autor:innen und Institutionen

  • Sami-Sabinsa Group Limited, 19/1&19/2, I Main, II Phase, Peenya Industrial Area, Bengaluru, Karnataka 560058, India. lakshmi@sami-sabinsagroup.com.
  • Sabinsa Corporation, 20 Lake Drive, East Windsor, NJ 08520, USA.
  • Apollo First Med Hospitals, 154, Poonamallee High Rd, Kilpauk, Chennai, Tamil Nadu 600010, India.
  • Santosh Hospital, 6, 1, Promenade Rd, Coles Park Pulikeshi Nagar, Bengaluru, Karnataka 560005, India.
  • Vijaya Super Specialty Hospital, 41-A, 16 II, Raghava Cine Complex Rd, Pogathota, Nellore, Andhra Pradesh 524001, India.

Zitieren

APA

Majeed, M., Nagabhushanam, K., Devarajan, T. V., Saklecha, S., Reddy, S. V. K., & Mundkur, L. (2023). A minor metabolite from Curcuma longa effective against metabolic syndrome: results from a randomized, double-blind, placebo-controlled clinical study. Food & Function. https://doi.org/10.1039/d2fo03627d

Vancouver

Majeed M, Nagabhushanam K, Devarajan TV, Saklecha S, Reddy SVK, Mundkur L. A minor metabolite from Curcuma longa effective against metabolic syndrome: results from a randomized, double-blind, placebo-controlled clinical study. Food & Function. 2023. doi:10.1039/d2fo03627d

BibTeX
@article{Majeed2023,
  author = {Majeed, Muhammed and Nagabhushanam, Kalyanam and Devarajan, T V and Saklecha, Santhosh and Reddy, S Venkata Krishna and Mundkur, Lakshmi},
  title = {A minor metabolite from Curcuma longa effective against metabolic syndrome: results from a randomized, double-blind, placebo-controlled clinical study},
  journal = {Food & Function},
  year = {2023},
  doi = {10.1039/d2fo03627d}
}
Kostenlos starten →